Powder: -20°C for 3 years
In solvent: -80°C for 2 years
JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210.
Description | JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4). JKE-1674 is an active metabolite of the GPX4 inhibitor ML-210. |
In vitro | JKE-1674 reduces the viability of LOX-IMVI cancer cells with an EC50 of 0.03 μM and in a panel of additional cancer cell lines. JKE-1674 is completely rescued by ferroptosis inhibitors[1]. |
In vivo | JKE-1674 (50?mg/kg; p.o.) could be detected in the serum of mice dosed orally with the compound[2]. |
Molecular Weight | 451.3 |
Formula | C20H20Cl2N4O4 |
CAS No. | 2421119-60-8 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 13 mg/mL (28.81 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JKE-1674 2421119-60-8 氧化还原 GPX ML210 glutathione Ferroptosis peroxidase inhibit JKE 1674 Glutathione Peroxidase rescued Inhibitor JKE1674 inhibitor